SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
Commission File Number 0-12850
NOTIFICATION OF LATE FILING
(Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F
[X] Form 10-Q [ ] Form N-SAR
For Period Ended: JUNE 30, 2000
----------------
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:__________________________________________
READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR
TYPE.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify Item(s) to which the notification relates:
-------------------------------------------------------------------------------
-------------------------------------------------------------------------------
PART I
REGISTRANT INFORMATION
Full name of registrant DENTAL/MEDICAL DIAGNOSTIC SYSTEMS, INC.
------------------------------------------------------
Former name if applicable
-------------------------------------------------------------------------------
Address of principal executive office (STREET AND NUMBER)
6416 VARIEL AVE.
-------------------------------------------------------------------------------
City, State and Zip Code WOODLAND HILLS, CALIFORNIA 91367
------------------------------------------------------
<PAGE>
PART II
RULE 12B-25 (B) AND (C)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[XX] (b) The subject annual report, semi-annual report, transition
report on Form 10-KSB, 20-F, 11-K or Form N-SAR, or portion
thereof will be filed on or before the 15th calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-KSB, 11-K, 20-F,
10-Q, N-SAR or the transition report portion thereof could not be filed within
the prescribed time period. (Attach extra sheets if needed.)
Dental/Medical Diagnostic Systems, Inc. could not file its Quarterly Report
on Form 10-Q for the year ended June 30, 2000 within the prescribed time period
because it was unable, without unreasonable effort or expense, to prepare and
file the required information to be incorporated therein.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
ROBERT H. GUREVITCH 818 932-2300
-------------------------------------------------------------------------------
(Name) (Area Code) (Telephone number)
(2) Have all other periodic reports required under Sections 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[XX] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[XX] Yes [ ] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
Dental/Medical Diagnostic Systems, Inc. will report a net loss of
approximately $3,176,971 in its second quarter of 2000 as compared to net income
of approximately $1,463,674 for the same period in 1999. The net loss in the
second quarter is primarily attributable to volume and margin deterioration of
the Apollo 95E and TeliCam product lines due to market saturation and the
planned phase-out of these product lines pending introduction of the Apollo E
and Apollo Cam, as well as a reassessment of corporate structure and methods of
operations, which is to be fully realized during the third quarter.
Page 2
<PAGE>
DENTAL/MEDICAL DIAGNOSTIC SYSTEMS, INC.
-------------------------------------------------------------------------------
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date AUGUST 14, 2000 By
-------------------- --------------------------------------------
Name: Robert H. Gurevitch
Title: Chairman and Chief Executive Officer
